Avidity Partners Management LP Dynavax Technologies Corp Transaction History

Avidity Partners Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $31.1 Million - $67.4 Million	-3,400,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $725,000 - $1.1 Million	-100,000 Reduced 2.86%	3,400,000 $33.5 Million
Q1 2021 May 17, 2021	SELL	$4.57 - $11.18 $2.29 Million - $5.59 Million	-500,000 Reduced 12.5%	3,500,000 $34.4 Million
Q4 2020 Feb 16, 2021	BUY	$3.73 - $5.6 $7.37 Million - $11.1 Million	1,975,000 Added 97.53%	4,000,000 $17.8 Million
Q3 2020 Nov 16, 2020	SELL	$4.32 - $11.7 $2.8 Million - $7.6 Million	-649,154 Reduced 24.28%	2,025,000 $8.75 Million
Q2 2020 Aug 14, 2020	SELL	$2.94 - $9.1 $3.38 Million - $10.5 Million	-1,149,846 Reduced 30.07%	2,674,154 $23.7 Million
Q1 2020 Jun 17, 2020	BUY	$2.27 - $6.2 $8.68 Million - $23.7 Million	3,824,000 New	3,824,000 $13.5 Million
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $1.77 Million - $4.84 Million	-780,000 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$3.46 - $6.93 $2.7 Million - $5.41 Million	780,000 New	780,000 $4.46 Million

275

129M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.